129 related articles for article (PubMed ID: 38668710)
1. Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
Aksamit TR; Locantore N; Addrizzo-Harris D; Ali J; Barker A; Basavaraj A; Behrman M; Brunton AE; Chalmers S; Choate R; Dean NC; DiMango A; Fraulino D; Johnson MM; Lapinel NC; Maselli DJ; McShane PJ; Metersky ML; Miller BE; Naureckas ET; O'Donnell AE; Olivier KN; Prusinowski E; Restrepo MI; Richards CJ; Rhyne G; Schmid A; Solomon GM; Tal-Singer R; Thomashow B; Tino G; Tsui K; Varghese SA; Warren HE; Winthrop K; Zha BS
Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38668710
[TBL] [Abstract][Full Text] [Related]
2. Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan.
Lin CY; Huang HY; Hsieh MH; Fang YF; Lo YL; Lin SM; Huang YT; Yeh CH; Wang CH; Lin HC
Front Microbiol; 2022; 13():868435. PubMed ID: 35509319
[TBL] [Abstract][Full Text] [Related]
3. Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study.
Drysdale M; Choate R; Brunton AE; Tiberi S; Gillespie IA; Lininger N; Shrimpton SB; Metersky M; Lapinel NC; McShane PJ; Richards CJ; Swenson C; Sharma H; Mannino D; Winthrop KL;
Pulm Pharmacol Ther; 2023 Dec; 83():102260. PubMed ID: 37741357
[TBL] [Abstract][Full Text] [Related]
4. Impact of concomitant nontuberculous mycobacteria and
Hsieh MH; Lin CY; Wang CY; Fang YF; Lo YL; Lin SM; Lin HC
Infect Drug Resist; 2018; 11():1137-1143. PubMed ID: 30127630
[TBL] [Abstract][Full Text] [Related]
5. Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.
Aksamit TR; O'Donnell AE; Barker A; Olivier KN; Winthrop KL; Daniels MLA; Johnson M; Eden E; Griffith D; Knowles M; Metersky M; Salathe M; Thomashow B; Tino G; Turino G; Carretta B; Daley CL;
Chest; 2017 May; 151(5):982-992. PubMed ID: 27889361
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Clinical Implications of Nontuberculous Mycobacteria Isolation and Infection among Patients with Bronchiectasis in the Jerusalem Area.
Kuint R; Azmanov H; Shalom A; Berkman N
Isr Med Assoc J; 2024 Mar; 26(3):180-185. PubMed ID: 38493330
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
Adjemian J; Olivier KN; Prevots DR
Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
[TBL] [Abstract][Full Text] [Related]
8. Association between bronchiectasis exacerbations and longitudinal changes in FEV
Aksamit TR; Lapinel NC; Choate R; Feliciano J; Winthrop KL; Schmid A; Wu J; Fucile S; Metersky ML;
Respir Med; 2024 Jul; 228():107660. PubMed ID: 38734153
[TBL] [Abstract][Full Text] [Related]
9. The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.
Blakney RA; Ricotta EE; Follmann D; Drew J; Carey KA; Glass LN; Robinson C; MacDonald S; McShane PJ; Olivier KN; Fennelly K; Prevots DR
BMC Infect Dis; 2022 Jan; 22(1):75. PubMed ID: 35062891
[TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry.
Metersky ML; Choate R; Aksamit TR; Conrad D; Lapinel NC; Maselli DJ; McShane PJ
Respir Med; 2022 Mar; 193():106746. PubMed ID: 35124355
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of patients with bronchiectasis with nontuberculous mycobacterial disease in Mainland China: a single center cross-sectional study.
Yin H; Gu X; Wang Y; Fan G; Lu B; Liu M; Wang C; Cao B; Wang C
BMC Infect Dis; 2021 Dec; 21(1):1216. PubMed ID: 34872515
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.
Henkle E; Aksamit TR; Barker AF; Curtis JR; Daley CL; Anne Daniels ML; DiMango A; Eden E; Fennelly K; Griffith DE; Johnson M; Knowles MR; Leitman A; Leitman P; Malanga E; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Prieto D; Salathe M; Thomashow B; Tino G; Turino G; Wisclenny S; Winthrop KL
Chest; 2017 Dec; 152(6):1120-1127. PubMed ID: 28479113
[TBL] [Abstract][Full Text] [Related]
13. Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis.
Bonaiti G; Pesci A; Marruchella A; Lapadula G; Gori A; Aliberti S
Biomed Res Int; 2015; 2015():197950. PubMed ID: 26106603
[TBL] [Abstract][Full Text] [Related]
14. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry.
Basavaraj A; Choate R; Addrizzo-Harris D; Aksamit TR; Barker A; Daley CL; Anne Daniels ML; Eden E; DiMango A; Fennelly K; Griffith DE; Johnson MM; Knowles MR; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Winthrop KL
Chest; 2020 Oct; 158(4):1376-1384. PubMed ID: 32622820
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.
Chalmers JD; Aliberti S; Filonenko A; Shteinberg M; Goeminne PC; Hill AT; Fardon TC; Obradovic D; Gerlinger C; Sotgiu G; Operschall E; Rutherford RM; Dimakou K; Polverino E; De Soyza A; McDonnell MJ
Am J Respir Crit Care Med; 2018 Jun; 197(11):1410-1420. PubMed ID: 29357265
[TBL] [Abstract][Full Text] [Related]
16. Chest Computed Tomography Features of Nontuberculous Mycobacterial Pulmonary Disease Versus Asymptomatic Colonization: A Cross-sectional Cohort Study.
Garcia B; Wilmskoetter J; Grady A; Mingora C; Dorman S; Flume P
J Thorac Imaging; 2022 May; 37(3):140-145. PubMed ID: 34292274
[TBL] [Abstract][Full Text] [Related]
17. Nontuberculous mycobacteria in diffuse panbronchiolitis.
Tsuji T; Tanaka E; Yasuda I; Nakatsuka Y; Kaji Y; Yasuda T; Hashimoto S; Hwang MH; Hajiro T; Taguchi Y
Respirology; 2015 Jan; 20(1):80-6. PubMed ID: 25269823
[TBL] [Abstract][Full Text] [Related]
18. Characterization of bronchoalveolar lavage fluid microbiota in acute exacerbations of bronchiectasis with non-tuberculous mycobacterial detection.
Xu Q; Mei Z; Zha Q; Chen J; Qin H; Liu B; Jie Z; Wu X
Int J Infect Dis; 2024 May; 146():107120. PubMed ID: 38821186
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of pulmonary artery dilation in non-cystic fibrosis bronchiectasis: a computed tomography analysis from a cohort of the US Bronchiectasis and Nontuberculous Mycobacteria Research Registry.
Karamooz E; Brixey AG; Rydzak CE; Primack SL; Markwardt S; Barker AF
J Thorac Dis; 2024 Feb; 16(2):1496-1502. PubMed ID: 38505050
[TBL] [Abstract][Full Text] [Related]
20. Association of low fat mass with nontuberculous mycobacterial infection in patients with bronchiectasis.
Lim SY; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
Medicine (Baltimore); 2021 Apr; 100(14):e25193. PubMed ID: 33832079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
